Logo image of SMG

SCOTTS MIRACLE-GRO CO (SMG) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:SMG - US8101861065 - Common Stock

63.72 USD
+0.92 (+1.46%)
Last: 1/21/2026, 8:04:00 PM
63.72 USD
0 (0%)
After Hours: 1/21/2026, 8:04:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to SMG. SMG was compared to 82 industry peers in the Chemicals industry. SMG has a medium profitability rating, but doesn't score so well on its financial health evaluation. SMG has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • SMG had positive earnings in the past year.
  • In the past year SMG had a positive cash flow from operations.
  • In multiple years SMG reported negative net income over the last 5 years.
  • SMG had a positive operating cash flow in 4 of the past 5 years.
SMG Yearly Net Income VS EBIT VS OCF VS FCFSMG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M 600M

1.2 Ratios

  • SMG has a Return On Assets of 5.30%. This is amongst the best in the industry. SMG outperforms 82.93% of its industry peers.
  • SMG has a Return On Invested Capital of 14.47%. This is amongst the best in the industry. SMG outperforms 93.90% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for SMG is above the industry average of 6.11%.
  • The last Return On Invested Capital (14.47%) for SMG is above the 3 year average (10.89%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.3%
ROE N/A
ROIC 14.47%
ROA(3y)-2.35%
ROA(5y)-1.31%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.89%
ROIC(5y)10.87%
SMG Yearly ROA, ROE, ROICSMG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200

1.3 Margins

  • SMG's Profit Margin of 4.25% is fine compared to the rest of the industry. SMG outperforms 67.07% of its industry peers.
  • In the last couple of years the Profit Margin of SMG has declined.
  • SMG has a better Operating Margin (12.96%) than 69.51% of its industry peers.
  • SMG's Operating Margin has declined in the last couple of years.
  • SMG has a Gross Margin (31.19%) which is in line with its industry peers.
  • SMG's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.96%
PM (TTM) 4.25%
GM 31.19%
OM growth 3Y6.65%
OM growth 5Y-2.32%
PM growth 3YN/A
PM growth 5Y-14.62%
GM growth 3Y5.81%
GM growth 5Y-1.12%
SMG Yearly Profit, Operating, Gross MarginsSMG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SMG is still creating some value.
  • The number of shares outstanding for SMG has been increased compared to 1 year ago.
  • SMG has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, SMG has an improved debt to assets ratio.
SMG Yearly Shares OutstandingSMG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
SMG Yearly Total Debt VS Total AssetsSMG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • An Altman-Z score of 2.73 indicates that SMG is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • SMG's Altman-Z score of 2.73 is fine compared to the rest of the industry. SMG outperforms 78.05% of its industry peers.
  • The Debt to FCF ratio of SMG is 7.69, which is on the high side as it means it would take SMG, 7.69 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of SMG (7.69) is better than 70.73% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 7.69
Altman-Z 2.73
ROIC/WACC1.26
WACC11.49%
SMG Yearly LT Debt VS Equity VS FCFSMG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B

2.3 Liquidity

  • SMG has a Current Ratio of 1.27. This is a normal value and indicates that SMG is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.27, SMG is doing worse than 84.15% of the companies in the same industry.
  • SMG has a Quick Ratio of 1.27. This is a bad value and indicates that SMG is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of SMG (0.47) is worse than 93.90% of its industry peers.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 0.47
SMG Yearly Current Assets VS Current LiabilitesSMG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 66.07% over the past year.
  • SMG shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -12.47% yearly.
  • Looking at the last year, SMG shows a decrease in Revenue. The Revenue has decreased by -3.93% in the last year.
  • SMG shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.75% yearly.
EPS 1Y (TTM)66.07%
EPS 3Y-3.11%
EPS 5Y-12.47%
EPS Q2Q%15.15%
Revenue 1Y (TTM)-3.93%
Revenue growth 3Y-4.54%
Revenue growth 5Y-3.75%
Sales Q2Q%-6.58%

3.2 Future

  • Based on estimates for the next years, SMG will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.99% on average per year.
  • SMG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.82% yearly.
EPS Next Y16.56%
EPS Next 2Y16.38%
EPS Next 3Y17.37%
EPS Next 5Y13.99%
Revenue Next Year0.44%
Revenue Next 2Y1.33%
Revenue Next 3Y1.96%
Revenue Next 5Y2.82%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SMG Yearly Revenue VS EstimatesSMG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B 4B
SMG Yearly EPS VS EstimatesSMG Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8

6

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 17.13, SMG is valued on the expensive side.
  • 62.20% of the companies in the same industry are more expensive than SMG, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of SMG to the average of the S&P500 Index (27.32), we can say SMG is valued slightly cheaper.
  • A Price/Forward Earnings ratio of 14.69 indicates a correct valuation of SMG.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of SMG indicates a somewhat cheap valuation: SMG is cheaper than 65.85% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 24.30. SMG is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 17.13
Fwd PE 14.69
SMG Price Earnings VS Forward Price EarningsSMG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • SMG's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of SMG indicates a rather cheap valuation: SMG is cheaper than 80.49% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 13.49
EV/EBITDA 11.15
SMG Per share dataSMG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of SMG may justify a higher PE ratio.
  • SMG's earnings are expected to grow with 17.37% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.03
PEG (5Y)N/A
EPS Next 2Y16.38%
EPS Next 3Y17.37%

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 4.12%, SMG is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.28, SMG pays a better dividend. On top of this SMG pays more dividend than 87.80% of the companies listed in the same industry.
  • SMG's Dividend Yield is rather good when compared to the S&P500 average which is at 1.86.
Industry RankSector Rank
Dividend Yield 4.12%

5.2 History

  • The dividend of SMG decreases each year by -18.28%.
  • SMG has been paying a dividend for at least 10 years, so it has a reliable track record.
  • SMG has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-18.28%
Div Incr Years0
Div Non Decr Years3
SMG Yearly Dividends per shareSMG Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

  • SMG pays out 106.27% of its income as dividend. This is not a sustainable payout ratio.
DP106.27%
EPS Next 2Y16.38%
EPS Next 3Y17.37%
SMG Yearly Income VS Free CF VS DividendSMG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M
SMG Dividend Payout.SMG Dividend Payout, showing the Payout Ratio.SMG Dividend Payout.PayoutRetained Earnings

SCOTTS MIRACLE-GRO CO

NYSE:SMG (1/21/2026, 8:04:00 PM)

After market: 63.72 0 (0%)

63.72

+0.92 (+1.46%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-05
Earnings (Next)01-28
Inst Owners74.56%
Inst Owner Change-0.18%
Ins Owners0.57%
Ins Owner Change-0.16%
Market Cap3.70B
Revenue(TTM)3.41B
Net Income(TTM)145.20M
Analysts81.67
Price Target73.78 (15.79%)
Short Float %8.09%
Short Ratio4.46
Dividend
Industry RankSector Rank
Dividend Yield 4.12%
Yearly Dividend2.69
Dividend Growth(5Y)-18.28%
DP106.27%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.7%
Min EPS beat(2)2.56%
Max EPS beat(2)12.85%
EPS beat(4)3
Avg EPS beat(4)10.9%
Min EPS beat(4)-0.27%
Max EPS beat(4)28.45%
EPS beat(8)6
Avg EPS beat(8)7.37%
EPS beat(12)9
Avg EPS beat(12)6.6%
EPS beat(16)11
Avg EPS beat(16)4.72%
Revenue beat(2)0
Avg Revenue beat(2)-3.72%
Min Revenue beat(2)-4.12%
Max Revenue beat(2)-3.33%
Revenue beat(4)1
Avg Revenue beat(4)-2.07%
Min Revenue beat(4)-6.02%
Max Revenue beat(4)5.18%
Revenue beat(8)3
Avg Revenue beat(8)-0.86%
Revenue beat(12)5
Avg Revenue beat(12)-0.15%
Revenue beat(16)5
Avg Revenue beat(16)-0.77%
PT rev (1m)0%
PT rev (3m)-2.69%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-13.31%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.99%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-15.79%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.11%
Valuation
Industry RankSector Rank
PE 17.13
Fwd PE 14.69
P/S 1.08
P/FCF 13.49
P/OCF 9.95
P/B N/A
P/tB N/A
EV/EBITDA 11.15
EPS(TTM)3.72
EY5.84%
EPS(NY)4.34
Fwd EY6.81%
FCF(TTM)4.72
FCFY7.41%
OCF(TTM)6.4
OCFY10.05%
SpS58.85
BVpS-6.16
TBVpS-17.3
PEG (NY)1.03
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 5.3%
ROE N/A
ROCE 22.09%
ROIC 14.47%
ROICexc 14.74%
ROICexgc 21.95%
OM 12.96%
PM (TTM) 4.25%
GM 31.19%
FCFM 8.02%
ROA(3y)-2.35%
ROA(5y)-1.31%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.89%
ROIC(5y)10.87%
ROICexc(3y)11.14%
ROICexc(5y)11.26%
ROICexgc(3y)16.21%
ROICexgc(5y)16.69%
ROCE(3y)16.63%
ROCE(5y)16.6%
ROICexgc growth 3Y24.46%
ROICexgc growth 5Y-7.91%
ROICexc growth 3Y20.33%
ROICexc growth 5Y-2.04%
OM growth 3Y6.65%
OM growth 5Y-2.32%
PM growth 3YN/A
PM growth 5Y-14.62%
GM growth 3Y5.81%
GM growth 5Y-1.12%
F-Score8
Asset Turnover1.24
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 7.69
Debt/EBITDA 3.96
Cap/Depr 129.87%
Cap/Sales 2.85%
Interest Coverage 3.37
Cash Conversion 71.78%
Profit Quality 188.64%
Current Ratio 1.27
Quick Ratio 0.47
Altman-Z 2.73
F-Score8
WACC11.49%
ROIC/WACC1.26
Cap/Depr(3y)111.47%
Cap/Depr(5y)111.25%
Cap/Sales(3y)2.61%
Cap/Sales(5y)2.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.07%
EPS 3Y-3.11%
EPS 5Y-12.47%
EPS Q2Q%15.15%
EPS Next Y16.56%
EPS Next 2Y16.38%
EPS Next 3Y17.37%
EPS Next 5Y13.99%
Revenue 1Y (TTM)-3.93%
Revenue growth 3Y-4.54%
Revenue growth 5Y-3.75%
Sales Q2Q%-6.58%
Revenue Next Year0.44%
Revenue Next 2Y1.33%
Revenue Next 3Y1.96%
Revenue Next 5Y2.82%
EBIT growth 1Y24.52%
EBIT growth 3Y1.8%
EBIT growth 5Y-5.98%
EBIT Next Year39.48%
EBIT Next 3Y16.5%
EBIT Next 5Y14.08%
FCF growth 1Y-53.06%
FCF growth 3YN/A
FCF growth 5Y-11.17%
OCF growth 1Y-44.37%
OCF growth 3YN/A
OCF growth 5Y-7.82%

SCOTTS MIRACLE-GRO CO / SMG FAQ

What is the ChartMill fundamental rating of SCOTTS MIRACLE-GRO CO (SMG) stock?

ChartMill assigns a fundamental rating of 5 / 10 to SMG.


What is the valuation status for SMG stock?

ChartMill assigns a valuation rating of 6 / 10 to SCOTTS MIRACLE-GRO CO (SMG). This can be considered as Fairly Valued.


Can you provide the profitability details for SCOTTS MIRACLE-GRO CO?

SCOTTS MIRACLE-GRO CO (SMG) has a profitability rating of 6 / 10.


What are the PE and PB ratios of SCOTTS MIRACLE-GRO CO (SMG) stock?

The Price/Earnings (PE) ratio for SCOTTS MIRACLE-GRO CO (SMG) is 17.13 and the Price/Book (PB) ratio is -10.34.


Can you provide the expected EPS growth for SMG stock?

The Earnings per Share (EPS) of SCOTTS MIRACLE-GRO CO (SMG) is expected to grow by 16.56% in the next year.